We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Anti–CTLA-4 treatment increases the diversity of the melanoma-specific CD8 T cell response.
No takes yet. Share an insight, caveat, or question.
Kvistborg et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: